Molecular Basis for the Selective Inhibition of Histone Deacetylase 6 by a Mercaptoacetamide Inhibitor
Year: 2018
Type: article
Abstract: Mercaptoacetamide histone deacetylase inhibitors are neuroprotective agents that do not exhibit the genotoxicity associated with more commonly used hydroxamate inhibitors. Here, we present the crystal structure of a selective mercaptoacetamide complexed with the C-terminal catalytic domain of HDAC6. When compared with the structure of a mercaptoacetamide bound to the class I isozyme HDAC8, different interactions are observed with the conserved tandem histidine pair in the active site. These differences likely contribute to the selectivity for inhibition of HDAC6, an important target for cancer chemotherapy and the treatment of neurodegenerative disease.
Source: ACS Medicinal Chemistry Letters
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: G1478526422, G1507827888, G321106277, Molecular basis of substrate recognition by histone deacetylase 6., Optimization of HDAC6 Inhibitors in the Treatment of CMT, G842756989, NE-CAT Center for Advanced Macromolecular Crystallography, Predoctoral Training at the Chemistry-Biology Interface, Structure and Function of Metalloenzymes
OpenAlex ID: W2900916306
